Search clinical trials for: Vascular access site closure

Total 128056 results

Terumo Europe N.V.
Terumo Medical Corporation

Recruiting

Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE)

Peripheral Vascular Disease | Hemostasis | Vascular Closure | Femoral Artery | Endovascular Procedure

France, Germany, Netherlands
Cardiva Medical, Inc.

Completed

AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID

Surgical Wound

United States
Cardiva Medical, Inc.

Completed

AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)

Surgical Wound

United States
Terumo Europe N.V.

Completed

Post-Market Clinical Investigation of the FemoSeal™ VCS: A Prospective, Multi-Center Observational European Study (FEMOSEAL CLOSE)

Peripheral Vascular Disease | Hemostasis | Vascular Closure | Endovascular Procedure

Belgium, France, Germany
Leipzig Heart Institute GmbH

Completed

Randomized Comparison of Catheter-based Strategies for Interventional Access Site Closure During Transfemoral Transcatheter Aortic Valve Implantation (CHOICE-CLOSURE)

Aortic Valve Stenosis

Germany
Second Affiliated Hospital, School of Medicine,...

Unknown

Feasibility and Safety of Total Percutaneous Closure of Femoral Arterial Access Sites in the Veno-arterial ECMO Patients

Extracorporeal Membrane Oxygenation | Myocarditis | Hypertension, Pulmonary | Heart Arrest | Pulmonary Embolism | Cardiogenic Shock | Medication Overdoses
Medstar Health Research Institute
Cardinal Health

Completed

The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure

Cardiac Diagnostic Procedure | Cardiac Interventional Procedure | Femoral Access Site Closure

United States
InSeal Medical Ltd.

Completed

InSeal VCD Large Bore Vascular Closure Device Safety and Effectiveness Clinical Study (InSealVCD)

Percutaneous Closure of Artery Access Sites

Israel
Rex Medical

Completed

The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System (Closer)

Surgical Wound

United States
Rex Medical

Completed

Clinical Investigation of the Rex Medical -Closer™ Vascular Closure System -Reduced Time to Ambulation Trial

Bleeding

Paraguay
Taewoong Medical Co., Ltd.

Terminated

Effectiveness and Safety Confirmation Between FASTSEAL® Bioabsorbable VCD and Perclose® ProGlide SMC System

The Patients Who Needed Hemostasis at the Puncture Site of Common Femoral Artety(CFA) Caused by Femoral Angiogram or Intervention After the Catheter Removal

Korea, Republic of
InSeal Medical Ltd.

Terminated

InSeal Vascular Closure Device Clinical Study Protocol (VCD)

Percutaneous Closure of Artery Access Sites

Germany
Cordis Corporation
Ensure Medical

Completed

Plug Arterial Closure System (PACS, 7F) (PACS 7F)

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary

Mexico
CardioDex
Sheba Medical Center

Withdrawn

Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 System

Coagulation | Therapeutic Uses | Pharmacologic Actions

Israel
CardioDex
Sheba Medical Center

Completed

Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose

Hemostasis,Surgical

Israel
Eli Lilly and Company

Recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES)

Overweight and Obesity

United States, Australia, Italy, Hungary, Spain, Canada, Germany, Argentina, Belgium, Czechia, Greece, Israel, Austria, Brazil, Mexico, Netherlands, Romania, India, United Kingdom, Slovakia, Poland, Turkey, Puerto Rico, France, Denmark
Eli Lilly and Company

Recruiting

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Elevated Lp(a) | Atherosclerotic Cardiovascular Disease (ASCVD)

United States, Australia, Spain, Canada, Argentina, China, Italy, France, Japan, Taiwan, Korea, Republic of, Denmark, Germany, Hungary, Israel, Austria, Belgium, Netherlands, Brazil, Mexico, Romania, United Kingdom, Greece, Czechia, Poland and more
Essential Medical, Inc.
Essential Medical LLC a subsidiary of Teleflex, Incorporated

Recruiting

Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes (ACCESS MANTA)

Femoral Arteriotomy Closure

United States
Eli Lilly and Company

Recruiting

A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk (ACHIEVE-4)

Cardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or Obesity

United States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Mexico, Romania, Brazil, Czechia, Germany, Argentina, Greece, Slovakia
The University of Queensland
Queensland Children's Hospital; Griffith University; Royal Brisbane and Women... and other collaborators

Recruiting

Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) (ProP)

Wound Infection | Catheter Infection | Catheter-Related Infections | Wound | Vascular Access Complication | Catheter Complications | Device Related Infection | Wound of Skin | Catheter Related Complication | Device Related Sepsis | Occlusive Dressings | Device Site Reactions

Australia, France
Novartis Pharmaceuticals

Recruiting

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Primary Prevention of Atherosclerotic Cardiovascular Disease

United States, China, Italy, Spain, France, Netherlands, Poland, Switzerland, Taiwan, Greece, Thailand, Brazil, India, Hungary, Latvia, Mexico, Israel, Malaysia, Turkey, Argentina, Singapore, Australia, Belgium, Bulgaria, Denmark, Croatia, South... and more
University of Washington
National Institute on Aging (NIA)

Recruiting

Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers (PICSI-M)

Liver Cirrhosis | Quality of Life | Neoplasm Metastasis | Pulmonary Disease, Chronic Obstructive | Peripheral Vascular Diseases | Dementia | Kidney Failure, Chronic | Chronic Disease | Lung Diseases, Interstitial | Health Communication | Lung Neoplasm | Heart Failure，Congestive | Patient Care | Health Care Quality... and other conditions

United States
Shanghai 10th People's Hospital

Not yet recruiting

Application of Vascular Closure Device in Transvenous Cardiac Intervention

Vascular Access Complications

China
Linkoeping University
Amra Medical AB

Recruiting

Relevance of Sarcopenia in Advanced Liver Disease (ACCESS-ESLD)

Liver Cirrhosis | Hepatocellular Carcinoma | Sarcopenia | Portal Hypertension

Sweden
IGLESIAS Juan Fernando
University of Bern

Recruiting

DIStal Versus COnventional Radial Access for COMPLEX Large-bore Percutaneous Coronary Intervention (DISCO COMPLEX)

Vascular Access Site Occlusion

Switzerland, Greece, Italy, Belgium
Hospital Universitari de Bellvitge

Recruiting

Intradermal Suture Versus Stapling for Groin Skin Closure in Vascular Surgery (VASC-INF Trial)

Surgical Site Infection

Spain
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; W.L.Gore & Associates; Abbott; Centre Hospitalier St... and other collaborators

Not yet recruiting

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years (CLOSE-2)

Patent Foramen Ovale | Cryptogenic Ischemic Stroke

France
Novartis Pharmaceuticals

Recruiting

Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia (ASC2ESCALATE)

Chronic Myelogenous Leukemia - Chronic Phase

United States
F.D. Roosevelt Teaching Hospital with Policlinic...

Not yet recruiting

Comparison of Ultrasound-guided and Palpation-inserted Peripheral Venous Cannula (CompOne)

Vascular Access Complication | Vascular Access Site Bruising
University Hospital Ostrava

Recruiting

Evaluation of Tissue Glue on PICC and Midline Catheters Insertion Sites

Adult Patients With Mid-term or Long-term Venous Access

Czechia
Abbott Medical Devices

Recruiting

Abbott Vascular Medical Device Registry (AV-MDR)

Acute Myocardial Infarction | Restenoses, Coronary | Coronary Artery Lesions | Venous Embolism | Arterial Embolism

United States, China, Hungary, Spain, Germany, Austria, Australia, Belgium, France, Italy, Netherlands, Switzerland, Taiwan, United Arab Emirates
Eli Lilly and Company

Recruiting

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-2)

Crohn's Disease

United States, Australia, Japan, India, Korea, Republic of, Canada, Turkey, Ukraine, Brazil, Mexico, Israel, Croatia, Hungary, Latvia, Lithuania, Serbia, China, Poland, Czechia, Slovakia, Switzerland, Russian Federation, Germany, Austria and more
Minneapolis Heart Institute Foundation

Recruiting

Radial vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH) (REBIRTH)

Patient Satisfaction | Vascular Access Complication

United States
Center for International Blood and Marrow Transplant...
National Marrow Donor Program

Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Autoimmune Diseases | Hodgkin Lymphoma | Hematologic Malignancies | Acute Lymphoblastic Leukemia (ALL) | Non-hodgkin Lymphoma | Severe Aplastic Anemia | Inherited Disorders of Metabolism | Inherited Abnormalities of Platelets | Histiocytic Disorders | Acute Myelogenous Leukemia (AML or ANLL) | Other Acute... and other conditions

United States
Medtronic Endovascular

Active, not recruiting

VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial

Venous Reflux

United States, Korea, Republic of, France, Australia, United Kingdom, Canada, Germany, Netherlands, Spain, Italy
Aurora Health Care

Completed

Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial (SAFE-VEIN)

Atrial Fibrillation | Heart Block | Bradycardia | Atrial Flutter | Sinus Node Dysfunction | Brady-tachy Syndrome | Pulmonary Embolism and Thrombosis | Mitral Valve Repair

United States
Deutsches Herzzentrum Muenchen

Completed

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation (ACCESS-TAVI)

Aortic Valve Stenosis

Germany
Amgen

Active, not recruiting

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial

Atherosclerotic Cardiovascular Disease

United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Italy, Portugal, Greece, Hong Kong, Hungary, United Kingdom, France, Bulgaria, Germany, Finland, Japan, Sweden, Canada, Denmark, Icelan... and more
AbbVie
Endo Pharmaceuticals; Allergan Sales, LLC; Acerus Pharmaceuticals Corporation; Upsher-Smith...

Completed

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men (TRAVERSE)

Cardiovascular Diseases | Hypogonadism

United States, Puerto Rico
GlaxoSmithKline

Completed

Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

Churg-Strauss Syndrome | Eosinophilic Granulomatosis With Polyangiitis

United States, France, Japan, Germany, Canada, United Kingdom, Belgium
Amgen

Completed

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Atherosclerotic Cardiovascular Disease

Canada, United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Hungary, Italy, Portugal, United Kingdom, Greece, Hong Kong, Turkey, France, Bulgaria, Germany, Finland, Japan, Sweden, ... and more
Eli Lilly and Company

Completed

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-1)

Crohn's Disease

China, United States, Spain, Australia, Austria, Belgium, India, Japan, Korea, Republic of, Israel, Russian Federation, Canada, Hungary, Poland, Italy, Turkey, Switzerland, Germany, Brazil, Argentina, Latvia, Romania, Slovakia, Ukraine, Denmar... and more
Casa Colina Hospital and Centers for Healthcare

Completed

Exploring Accessible Beauty for Individuals With Upper Extremity Deficits

Multiple Sclerosis | Amyotrophic Lateral Sclerosis | Muscular Dystrophies | Graves Disease | Myasthenia Gravis | Traumatic Brain Injury | Stroke, Ischemic | Stroke, Acute | Stroke Hemorrhagic | SCI - Spinal Cord Injury | Guillain-Barre Syndrome | Lupus Erythematosus | Stroke (CVA) or TIA | Ehlers-Danlos Syndromes...

United States
University of Washington
National Institute on Aging (NIA)

Completed

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) (PICSI-H)

Liver Cirrhosis | Neoplasm Metastasis | Pulmonary Disease, Chronic Obstructive | Dementia | Kidney Failure, Chronic | Chronic Disease | Peripheral Vascular Disease | Lung Diseases, Interstitial | Health Communication | Lung Neoplasm | Heart Failure，Congestive | Patient Care | Health Care Quality, Access, and Evaluation and other conditions

United States
University of Washington

Active, not recruiting

Facilitating Communication Study (FCS2)

Liver Cirrhosis | Cerebrovascular Disorders | Lung Diseases | Brain Injuries | Neoplasm Metastasis | Pulmonary Disease, Chronic Obstructive | Kidney Failure, Chronic | Chronic Disease | Multiple Organ Failure | Heart Failure, Congestive | Lung Neoplasm | Intensive Care Units | Health Care Quality, Access, and Evaluation and other conditions

United States
David Kong, M.D.
Medtronic Vascular; Terumo Medical Corporation; Volcano Corporation

Terminated

Study of Access Site for Enhancing PCI in STEMI for Seniors (SAFE STEMI for Seniors)

Myocardial Infarction

United States
University of Washington
National Institute on Aging (NIA)

Active, not recruiting

Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2) (PICSI-H)

Liver Cirrhosis | Quality of Life | Lung Neoplasms | Neoplasm Metastasis | Pulmonary Disease, Chronic Obstructive | Dementia | Kidney Failure, Chronic | Chronic Disease | Peripheral Vascular Disease | Lung Diseases, Interstitial | Health Communication | Heart Failure，Congestive | Patient Care | Health Care Quality... and other conditions

United States
Nektar Therapeutics
Eli Lilly and Company

Terminated

A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) (INSTRUCT-UC)

Colitis, Ulcerative

Australia, India, United States, Korea, Republic of, Hungary, United Kingdom, Japan, Argentina, Belgium, Brazil, Canada, China, Czechia, France, Georgia, Israel, Latvia, Poland, Romania, Russian Federation, Slovakia, Ukraine
Chiesi Farmaceutici S.p.A.

Terminated

Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality (READY 1)

Thrombosis | Catheter Occlusion

United States, Argentina, Belgium, Czechia, Poland, Romania, Spain
Becton, Dickinson and Company

Completed

An Observational Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors

Catheter Related Complication | Vascular Access Site Management | Disinfecting Cap

Belgium, Austria, Spain, Italy

Search clinical trials for: Vascular access site closure

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations